Healthcare Professionals
Please log in for special information and services
Modestas Jocius, PhD. Pharm Regional Manager Baltics

“It is a privilege to apply my pharmaceutical and business education and more than 25 years of professional experience to improve the lives of people with rare diseases in Estonia. We have been operating here since 2009 and will continue to provide innovative and efficient treatment solutions!"

Facts & Figures

AOP Orphan is fully dedicated to pharmaceutical and clinical development as well as commercialization of drugs for more than 20 years already.

Our motivation at AOP Orphan is to help patients who suffer from rare diseases. We achieve this cooperating with stakeholders of the Estonian health care system. Partnerships within pharmaceutical and health care industry are crucial for finding and providing solutions for patients, especially in the treatment of orphan diseases. 

Estonia occupies a special position among many countries where AOP Orphan is represented. In this market, the company began its development in 2009 with a local team  in the Marketing & Sales, and Medical for all three therapeutic divisions.

 

100,000
people
PATIENTS WITH RARE DISEASES IN estonia
In Europe those diseases that occur in less than 5 per 10,000 residents are defined as rare diseases. In Estonia 100,000 people have been diagnosed with a rare disease.
AVAILABLE TREATMENTS
In Estonia AOP Orphan provides seven products. 
 
7
products
2
areas
two THERAPEUTIC AREAS
AOP Orphan in Estonia covers two area of treatments: Cardiology & Pulmonology, Neurology and Metabolic Disorders.

Vision & Mission

Milestones